Long-term results with the Biocor-SJM stentless porcine aortic bioprosthesis

Journal of Heart Valve Disease

Volumn 11, Issue 1, 2002, Pages 47-53

  Vrandecic, Mario ^a   Fantini, Fernando Antonio ^a   Filho, Bayard Gontijo ^a   de Oliveira, Ozanan César ^a   da Costa Júnior, Idail Martins ^a   Vrandecic, Erika ^a  

^a BIOCOR INSTITUTO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE;

ADULT; AGED; AORTA VALVE DISEASE; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DEATH; DEMOGRAPHY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE MASS; HEMODYNAMICS; HOSPITALIZATION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTHESIS FAILURE; REOPERATION; RHEUMATIC HEART DISEASE; STENT; SURVIVAL; SWINE; TISSUE DEGENERATION; TREATMENT INDICATION; TREATMENT OUTCOME; AORTA VALVE; AORTA VALVE STENOSIS; BIOPROSTHESIS; DOPPLER ECHOCARDIOGRAPHY; HEART VALVE PROSTHESIS; MIDDLE AGED; SURVIVAL RATE; SUTURING METHOD;

ADULT; AGED; AORTIC VALVE; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; BIOPROSTHESIS; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; REOPERATION; SURVIVAL RATE; SUTURE TECHNIQUES; TREATMENT OUTCOME;

EID: 0036372014     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ross DN. Homograft replacement of the aortic valve. Lancet 1962;2:487-488
2. Yacoub M, Rasmi NRH, Sundt TM, et al. Fourteen-year experience with homovital homografts for aortic valve replacement. J Thorac Cardiovasc Surg 1995;110:186-194
3. O'Brien MF, Harrocks S, Stafford EG, et al. The homograft aortic valve: A 29-years, 99.3% follow up of 1,022 valve replacements. J Heart Valve Dis 2001;10:334-345
4. Maselli D, Pizio R, Pasquale LB, Di Bella I, De Gasperis C. Left ventricular mass reduction after valve replacement: homografts, and stented valves. Ann Thorac Surg 1999;67:966-971
5. Christakis GT, Joyner CD, Morgan CD, et al. Left ventricular mass regression early after aortic valve replacement. Ann Thorac Surg 1996;62:1084-1089
6. Jin XY, Pillai R, Westby S. Medium-term determinants of left ventricular mass index after valve replacement. Ann Thorac Surg 1999;67:411-416
7. Edmunds, LHJ, Clark RE, Cohn LH, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. J Thorac Cardiovasc Surg 1998;96:351-353
8. Bodnar E, Butchart EG, Bamford J, Besselaar AMPH, Grunkemeier GL, Frater RWM. Proposal for reporting thrombosis, embolism and bleeding after heart valve replacement. J Heart Valve Dis 1994;3:120-123
9. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol 1976;37:7-11
10. Skjaerpe T, Hegranaes L, Hatle L. Noninvasive estimation of valve area in patients with aortic stenosis by Doppler ultrasound and two-dimensional echocardiography. Circulation 1985;72:810
11. Dean AG, Dean JA, Coulombier D, et al. Epi Info, Version 6: Word Processing, Database and Statistics Program for Epidemiology on microcomputers. Centers of Disease Control and Preservation, Atlanta, Georgia, USA, 1994
12. Campos Filho N, Franco EL. KMSURV - A micro-computer program for univariate survival data analysis. Comp Methods Prog Biomed 1998;27:223-228
13. David TE, Puschmann R, Ivanov J, et al. Aortic valve replacement with stentless and stented porcine valves: A case match study. J Thorac Cardiovasc Surg 1998;117:267-272
14. Del Rizzo DF, Abdoh A, Cartier P, et al. The effect of prosthetic valve type on survival after aortic valve surgery. Semin Thorac Cardiovasc Surg 1999;11:1-8
15. Vrandecic M, Fantini FA, Gontijo Filho B, Oliveira OC, Costa Júnior IM, Vrandecic E. Retrospective clinical analysis of stented vs. stentless porcine bioprosthesis. Eur J Cardiothorac Surg 2000;18:46-53
16. David TE. The Toronto SPV bioprosthesis: Clinical and hemodynamic results at 6 years. Ann Thorac Surg 1999;68:S-9-S-13
17. Vrandecic MP, Gontijo BF, Fantini FA, et al. Clinical results with the use of the SJM Biocor stentless aortic valve at 7 years. In: Huysmans HA, David TE, Westaby S (ed.). Stentless Bioprosthesis. Second edition. Isis Medical Ltd., Oxford, 1999:53-58
18. Dellgren G. Erikson M, Brodin LA, Radegran K. The extended Biocor stentless aortic bioprosthesis. Early clinical experience. Scand Cardiovasc J 1999;33:259-264
19. Westaby S, Horton M, Jin XY, et al. Survival advantage of stentless aortic bioprostheses. Ann Thorac Surg 2000;70:785-791
20. Kaplon RJ, Cosgrove DM, III, Gillinov AM, et al. Cardiac valve replacement in patients on dialysis: Influence of prosthesis on survival. Ann Thorac Surg 2000;70:438-441
21. Gontijo FB, Vrandecic M, Fantini FA, Oliveira MH, Avelar SO. Porcine stentless aortic valve in replacements and acute aortic endocarditis. J Heart Valve Dis 1995;4:171-175